EMBO - the idea, the achievements and future perspectives

 EMBO - the idea, the  achievements and future perspectives

Speaker: Hermann Bujard

Affiliation: Executive Director of the European Molecular Biology Organization (EMBO)

Host: Claudina Rodrigues-Pousada

Short CV:

Professor Hermann Bujard is the current Executive Director of the European Molecular Biology Organization (EMBO) in Heidelberg, Germany. He also maintains an active research laboratory at Heidelberg’s Center for Molecular Biology (ZMBH), where his current research focuses on the development of vaccines against malaria. He has been an EMBO Member since 1976 and also served on the EMBO Council from 1989-1995
Professor Bujard’s group at ZMBH focused for many years on the mechanisms of transcription control in prokaryotes and eukaryotes. An interesting by-product of this research was the development of the tetracycline-dependent transcription control system, now widely applied in the study of gene function. Today, the Bujard group investigates malaria and the development of vaccines against P. Falciparum infections.
Professor Bujard has published 140 peer-reviewed articles and holds 25 international patents.
Professor Bujard has served on a number of international scientific committees and participated in the founding committees of several German institutes. Among other awards and memberships, he is a member of the Max Planck Institute for Medical Research, holds an honorary doctorate from the University of Würzburg, and has been awarded the Karl Heinz Beckurts Prize, the Yvette Mayent Prize for Cancer Research and the 2005 Medal of Merit from the German state of Baden-Württemberg.